FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
+0.07%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$18.4B
AUM Growth
-$1.1B
(-5.7%)
Cap. Flow
-$739M
Cap. Flow
% of AUM
-4.02%
Top 10 Holdings %
Top 10 Hldgs %
40.19%
Holding
562
New
65
Increased
161
Reduced
196
Closed
78
Top Buys
| 1 |
Intercontinental Exchange
ICE
|
$165M |
| 2 |
Incyte
INCY
|
$123M |
| 3 |
Danaher
DHR
|
$111M |
| 4 |
Bank of America
BAC
|
$107M |
| 5 |
Autodesk
ADSK
|
$95.4M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$234M |
| 2 |
Apple
AAPL
|
$182M |
| 3 |
ASML
ASML
|
$133M |
| 4 |
Altria Group
MO
|
$125M |
| 5 |
AGN
Allergan plc
AGN
|
$120M |
Sector Composition
| 1 | Technology | 21.48% |
| 2 | Communication Services | 18.39% |
| 3 | Healthcare | 16.44% |
| 4 | Consumer Discretionary | 11.83% |
| 5 | Industrials | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Chevron
CVX
$310B
| $552K | ﹤0.01% |
4,690
-2,700
| -37% | -$318K |
|
327
Aecom
ACM
$16.8B
| $530K | ﹤0.01% |
14,585
| – | – |
|
|
CVA
328
DELISTED
Covanta Holding Corporation
CVA
| $508K | ﹤0.01% |
32,575
| – | – |
|
|
GWPH
329
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $503K | ﹤0.01% |
4,500
+1,000
| +29% | +$112K |
|
330
Bread Financial
BFH
$3.09B
| $493K | ﹤0.01% |
2,704
-1,376
| -34% | -$251K |
|
331
Goldman Sachs
GS
$223B
| $481K | ﹤0.01% |
2,010
-228,484
| -99% | -$54.7M |
|
332
Illumina
ILMN
$15.7B
| $448K | ﹤0.01% |
3,598
+1,028
| +40% | +$128K |
|
|
PTHN
333
DELISTED
Patheon N.V.
PTHN
| $431K | ﹤0.01% |
15,000
-45,341
| -75% | -$1.3M |
|
|
DBVT
334
DBV Technologies
DBVT
$245M
| $427K | ﹤0.01% |
1,215
| – | – |
|
335
New Oriental
EDU
$7.98B
| $414K | ﹤0.01% |
+9,825
| New | +$414K |
|
|
HIND
336
Vyome Holdings, Inc. Common Stock
HIND
$210M
| – | – |
0
| – | – |
|
337
MetLife
MET
$52.9B
| $377K | ﹤0.01% |
+7,854
| New | +$377K |
|
338
HCA Healthcare
HCA
$98.5B
| $366K | ﹤0.01% |
4,940
-637,248
| -99% | -$47.2M |
|
339
Credicorp
BAP
$20.7B
| $347K | ﹤0.01% |
+2,200
| New | +$347K |
|
340
Fortis
FTS
$24.8B
| $334K | ﹤0.01% |
+10,816
| New | +$334K |
|
|
HAR
341
DELISTED
Harman International Industries
HAR
| $334K | ﹤0.01% |
3,007
-4,914
| -62% | -$546K |
|
342
Devon Energy
DVN
$22.1B
| $326K | ﹤0.01% |
7,145
-18,130
| -72% | -$827K |
|
343
Amicus Therapeutics
FOLD
$2.46B
| $298K | ﹤0.01% |
60,000
-50,150
| -46% | -$249K |
|
344
Ionis Pharmaceuticals
IONS
$9.76B
| $287K | ﹤0.01% |
+6,000
| New | +$287K |
|
345
Supernus Pharmaceuticals
SUPN
$2.58B
| $253K | ﹤0.01% |
10,000
-20,000
| -67% | -$506K |
|
346
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.3M
| $245K | ﹤0.01% |
+1,750
| New | +$245K |
|
|
RARX
347
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $223K | ﹤0.01% |
+14,654
| New | +$223K |
|
348
Exelixis
EXEL
$10.2B
| $194K | ﹤0.01% |
13,000
-10,000
| -43% | -$149K |
|
349
JB Hunt Transport Services
JBHT
$13.9B
| $194K | ﹤0.01% |
+2,000
| New | +$194K |
|
350
Maximus
MMS
$4.97B
| $190K | ﹤0.01% |
3,397
-126,692
| -97% | -$7.09M |
|